Literature DB >> 20197670

Metabolic syndrome in children: comparison of the International Diabetes Federation 2007 consensus with an adapted National Cholesterol Education Program definition in 300 overweight and obese French children.

Céline Druet1, Ken Ong, Claire Levy Marchal.   

Abstract

BACKGROUND/AIMS: Former definitions of metabolic syndrome (MS) in children have been adapted from adult MS definitions using age-related thresholds for each biochemical component, whereas the International Diabetes Federation (IDF) definition is based on absolute values. We compared the IDF childhood MS definition (IDF-MS) to the adapted National Cholesterol Education Program (adapted-NCEP) definition in overweight children.
METHODS: 300 overweight and obese children were included with a median age of 11 years and BMI SDS of +4.7.
RESULTS: Below 10 years of age, the frequency of MS according to the adapted-NCEP-MS definition was 18.6%, and 86.1% had abdominal obesity. In children aged 10 to <16 years (n = 214), the frequency of IDF-MS was 8.9% compared to 14.5% by adapted-NCEP. IDF-MS children had a larger waist circumference, and higher triglycerides, fasting insulin and tended to be older than the intermediate severity group of children with MS only according to adapted-NCEP. Children with MS only according to adapted-NCEP (IDF-MS negative), differed from non-MS children in systolic blood pressure, triglycerides and high-density lipoprotein cholesterol.
CONCLUSIONS: The recent IDF-MS criterion in children represents a more severe definition and appears to identify a group of children with higher fasting insulin than the adapted-MS definition which uses age-related thresholds (90th percentile). Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197670     DOI: 10.1159/000284359

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  7 in total

1.  The absence of insulin resistance in metabolic syndrome definition leads to underdiagnosing of metabolic risk in obese patients.

Authors:  Selim Kurtoglu; Leyla Akin; Mustafa Kendirci; Nihal Hatipoglu; Ferhan Elmali; Mümtaz Mazicioglu
Journal:  Eur J Pediatr       Date:  2012-03-28       Impact factor: 3.183

2.  Metabolic Syndrome and Prediabetes Among Yemeni School-Aged Children.

Authors:  Walid Saeed; Molham Al-Habori; Riyadh Saif-Ali; Ekram Al-Eryani
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-20       Impact factor: 3.168

3.  Prevalence of the metabolic syndrome among children from six cities of China.

Authors:  Haiquan Xu; Yanping Li; Ailing Liu; Qian Zhang; Xiaoqi Hu; Hongyun Fang; Tingyu Li; Hongwei Guo; Ying Li; Guifa Xu; Jun Ma; Lin Du; Guansheng Ma
Journal:  BMC Public Health       Date:  2012-01-06       Impact factor: 3.295

4.  Validation of surrogate markers for metabolic syndrome and cardiometabolic risk factor clustering in children and adolescents: A nationwide population-based study.

Authors:  Ji-Young Seo; Jae Hyun Kim
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 5.  Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies.

Authors:  R-C Huang; Susan L Prescott; Keith M Godfrey; Elizabeth A Davis
Journal:  J Nutr Sci       Date:  2015-04-10

6.  Normal weight estonian prepubertal boys show a more cardiovascular-risk-associated adipose tissue distribution than austrian counterparts.

Authors:  Sandra J Wallner-Liebmann; Reinhard Moeller; Renate Horejsi; Toivo Jürimäe; Jaak Jürimäe; Jarek Mäestu; Priit Purge; Meeli Saar; Erwin Tafeit; Petra Kaimbacher; Renate Kruschitz; Daniel Weghuber; Wolfgang J Schnedl; Harald Mangge
Journal:  ISRN Obes       Date:  2013-01-14

7.  Clinical and metabolic effect of a multidisciplinary intervention through a comprehensive care program for children and adolescents with obesity

Authors:  Nora Alejandra Zuluaga; Adriana Osorno; Alba Lozano; Oscar Villada
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.